AI assistant
Camlin Fine Sciences Ltd — Regulatory Filings 2021
Oct 1, 2021
59255_rns_2021-10-01_e8ceda64-dcfd-491c-9a6c-b5d8989d7a34.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [100 x 31] intentionally omitted <==
1[st] October, 2021
||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**CompanyScripCode: 532834|To,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|
Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)
Achievement of 100% capacity utilisation for the month of September 2021 at the Company’s Diphenol manufacturing plant situated at Dahej, Gujarat
Dear Sirs,
We wish to inform you that the company has successfully achieved 100% capacity utilisation for the month of September 2021 at its Diphenol manufacturing plant at Dahej SEZ, District Bharuch, Gujarat.
Kindly take the above information on records.
Thanking You, For Camlin Fine Sciences Limited Santosh Parab Chief Financial Officer
==> picture [426 x 57] intentionally omitted <==